SCIENTURE HOLDINGS, INC. Amortization of Debt Discount (Premium)
SCIENTURE HOLDINGS, INC. (SCNX) reported Amortization of Debt Discount (Premium) of $96.94 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-12-31 was $411.11K, a 54.28% decline year-over-year.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-09-30 was $1.76M.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-06-30 was $485.52K.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-03-31 was $509.12K.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2025 was $3.16M, a 246.44% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2024 was $912.45K.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2018 was $152.00, a 99.83% decline from fiscal 2017.
- SCIENTURE HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2017 was $88.65K, a 20.34% decline from fiscal 2016.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 3 month as first filed | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 6 month as first filed | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 9 month as first filed | Amortization of Debt Discount (Premium) 12 month | Amortization of Debt Discount (Premium) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $96.94K 10-Q · filed 2026-08-13 | |||||||
| 2025-12-31 | $411.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.17M derived: sum of 2 quarters · filed 2026-03-30 | $2.65M derived: sum of 3 quarters · filed 2026-08-13 | $3.16M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.24M derived: sum of 2 quarters · filed 2026-08-13 | $2.75M 10-Q · filed 2025-11-12 | $3.65M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $485.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $994.64K 10-Q · filed 2026-08-13 | $1.89M derived: sum of 3 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $509.12K 10-Q · filed 2026-05-15 | $1.41M derived: sum of 2 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | $899.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $912.45K 10-K · filed 2026-03-30 | ||||||
| 2024-09-30 | $13.18K 10-Q · filed 2025-11-12 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $152.00 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $0.00 derived: sum of 2 quarters · filed 2019-10-28 | $152.00 10-Q · filed 2019-10-28 | $2.57K derived: sum of 4 quarters · filed 2019-10-28 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26 | $152.00 10-Q · filed 2019-07-26 | $2.57K derived: sum of 3 quarters · filed 2019-07-26 | $14.78K derived: sum of 4 quarters · filed 2019-07-26 | ||||
| 2018-03-31 | $152.00 10-Q · filed 2019-05-13 | $2.57K derived: sum of 2 quarters · filed 2019-05-13 | $14.78K derived: sum of 3 quarters · filed 2019-05-13 | $41.20K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | $2.42K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $14.63K derived: sum of 2 quarters · filed 2019-03-22 | $41.04K derived: sum of 3 quarters · filed 2019-03-22 | $88.65K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $12.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $38.62K derived: sum of 2 quarters · filed 2018-10-26 | $86.22K 10-Q · filed 2018-10-26 | $120.77K derived: sum of 4 quarters · filed 2018-10-26 | ||||
| 2017-06-30 | $26.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $74.02K 10-Q · filed 2018-07-27 | $108.56K derived: sum of 3 quarters · filed 2018-07-27 | $127.11K derived: sum of 4 quarters · filed 2018-07-27 | ||||
| 2017-03-31 | $47.60K 10-Q · filed 2018-04-27 | $82.15K derived: sum of 2 quarters · filed 2018-04-27 | $100.69K derived: sum of 3 quarters · filed 2018-04-27 | $120.87K derived: sum of 4 quarters · filed 2018-04-27 | ||||
| 2016-12-31 | $34.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $53.09K derived: sum of 2 quarters · filed 2018-03-02 | $73.26K derived: sum of 3 quarters · filed 2018-03-02 | $111.29K 10-K · filed 2018-03-02 | ||||
| 2016-09-30 | $18.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $38.72K derived: sum of 2 quarters · filed 2017-11-07 | $76.75K 10-Q · filed 2017-11-07 | $137.81K 10-Q · filed 2016-11-14 | $114.77K derived: sum of 4 quarters · filed 2017-11-07 | |||
| 2016-06-30 | $20.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $58.20K 10-Q · filed 2017-08-04 | $99.32K 10-Q · filed 2016-08-05 | $96.22K derived: sum of 3 quarters · filed 2017-08-04 | $134.24K derived: sum of 4 quarters · filed 2017-08-04 | |||
| 2016-03-31 | $38.02K 10-Q · filed 2017-05-15 | $59.02K 10-Q · filed 2016-04-20 | $76.05K derived: sum of 2 quarters · filed 2017-05-15 | $114.07K derived: sum of 3 quarters · filed 2017-05-15 | $139.42K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $38.02K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $76.05K derived: sum of 2 quarters · filed 2017-03-30 | $101.40K derived: sum of 3 quarters · filed 2017-03-30 | $101.40K 10-K · filed 2017-03-30 | $111.67K 10-K · filed 2016-03-28 | |||
| 2015-09-30 | $38.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $63.37K derived: sum of 2 quarters · filed 2016-11-14 | $63.37K 10-Q · filed 2016-11-14 | $63.37K derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $25.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $25.35K 10-Q · filed 2016-08-05 | $25.35K derived: sum of 3 quarters · filed 2016-08-05 | $25.35K derived: sum of 4 quarters · filed 2016-08-05 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-04-20 | $0.00 derived: sum of 2 quarters · filed 2016-04-20 | $0.00 derived: sum of 3 quarters · filed 2016-04-20 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-03-28 | $0.00 10-K · filed 2016-03-28 | |||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | ||||||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |